SILK stock forecast
Our latest prediction for Silk Road Medical, Inc.'s stock price was made on the Aug. 8, 2019 when the stock price was at 40.43$.
In the short term (2weeks), SILK's stock price should outperform the market by 0.25%. During that period the price should oscillate between -7.72% and +9.00%.
In the medium term (3months), SILK's stock price should outperform the market by 4.07%. During that period the price should oscillate between -15.71% and +23.79%.Get email alerts
About Silk Road Medical, Inc.
Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The firm's devices enable vascular access via a puncture adjacent to the collarbone instead of the traditional approach of accessing the vascular system through the groin. Its products include ENROUTE Transcarotid Neuroprotection & Stent System. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.
At the moment the company generates 56M USD in revenues.
On its last earning announcement, the company reported a loss of -1.55$ per share.
The book value per share is 2.75$
Three months stock forecastAug. 8, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|